FDA expands obesity treatment options with approval of oral semaglutide (Wegovy) and orforglipron (Foundayo), shifting GLP-1 therapy from weekly injections to daily pills.

Robert F. Kennedy Jr. has released a new charter that expands the types of experts who can serve on the panel.

The once daily, oral glucagon-like peptide-1 receptor agonist was approved based on phase 3 data from ATTAIN-1 and ATTAIN-2.

Vaccination effective for preventing hospitalization and outpatient visits in children aged 6 months to 17 years ...

Another company, Amgen, is also expanding its TrumpRx offerings to include the arthritis drug Enbrel and psoriasis drug Otezla. The site now lists more than 61 discounted medications, up from about 40 ...

Generic dapagliflozin is now approved for adults with type 2 diabetes, though current labeling excludes chronic kidney disease and pediatric use.

HealthDay News — Switching to integrase strand transfer inhibitors (INSTI) from protease inhibitors is associated with new diabetes risk in people with HIV, according to a study published online March ...

203 kava exposures reported in 2025; reports involving combined use of kava and kratom reached 30 percent of all kava reports in 2025 ...

Findings based on analysis of reviews vs other methods, including nicotine replacement and non-nicotine e-cigarettes.

HealthDay News — The US is planning new tariffs on some name-brand medicines. The move could affect drug prices and how medicines are made. Officials say tariffs could reach as high as 100% on certain ...

The FDA is expected to decide on treatments for ADHD, Alzheimer disease, breast cancer, diabetes, and myasthenia gravis.

The proposed 2027 budget would give HHS about $111.1 billion, down roughly $15.8 billion from its current funding. The plan comes from President Donald Trump, but Congress will decide what actually ...